Evidence map›Paper›PMID 16080205›Full record

ArticleCell motility and the cytoskeleton2005

Differential effects of Latrunculin-A on myofibrils in cultures of skeletal muscle cells: insights into mechanisms of myofibrillogenesis.

Jushuo Wang, Jean M Sanger, Joseph W Sanger

Open access · greenAbstract read
In one paragraph

Article in Cell motility and the cytoskeleton, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 54 citations in OpenAlex.

  1. Curvature-Directed Elongation and Chiral Tilting Drive Asymmetric Tissue Patterning.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Mechanisms of actin disassembly and turnover.The Journal of cell biology · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Sarcomeric TPM3α in developing chicken.Cytoskeleton (Hoboken, N.J.) · 2018
    Article
  13. Article
  14. Article
  15. Creatine kinase B is necessary to limit myoblast fusion during myogenesis.American journal of physiology. Cell physiology · 2015
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jushuo WangDepartment of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6058, USA.
Jean M Sanger
Joseph W Sanger
University of Pennsylvania · US

Funding

MYOFIBRILLOGENESIS IN LIVING CARDIAC MUSCLE CELLSR01HL048954 · NHLBI · UPSTATE MEDICAL UNIVERSITY · PI SANGER, JOSEPH WILLIAM · 1995 to 2006
$2.7M
MYOFIBRILLOGENESIS IN LIVING SKELETAL MUSCLE CELLSR01AR046481 · NIAMS · UPSTATE MEDICAL UNIVERSITY · PI SANGER, JOSEPH WILLIAM · 2000 to 2004
$1.5M
NHLBI NIH HHS R01 HL048954NIAMS NIH HHS R01 AR046481
6 · The paper itself

Abstract

To test different models of myofibrillogenesis, we followed live cells expressing Green Fluorescent Proteins ligated to either actin or alpha-actinin and analyzed stress fibers, premyofibrils, and myofibrils in quail myotube cultures. Actin filaments in the three types of fibers were compared by analyzing the effects of Latrunculin-A (Lat-A), a monomeric actin binding macrolide drug (M.W. = 422 Daltons), on stress fibers in fibroblasts and on myofibrils in skeletal myotubes in the same culture. Lat-A, at low concentrations (0.2 microM), induced the loss of stress fibers in fibroblasts within a few hours and within 10 min when Lat-A was increased to 1.0 microM. The effect was reversible with reformation of the stress fibers when the drug was removed. In contrast to the Lat-A induced disassembly of stress fibers in fibroblasts, assembling myofibrils in the skeletal muscle cells were not affected by 1.0-microM concentrations of Lat-A. With increasing concentrations of Lat-A (up to 5 microM), and increasing incubation times, however, the drug induced premyofibrils, the precursors of mature myofibrils, to disassemble and the accumulation of mature myofibrils to be halted. Removal of the drug led to the reformation of premyofibrils and the resumption of myofibrillogenesis in the spreading edges of the myotubes. In contrast, the mature myofibrils in the central shaft of the myotubes were stable in doses of Lat-A as high as 50 microM. The newly assembled mature myofibrils located adjacent to the premyofibrils at the ends and sides of the myotube were intermediate in sensitivity to Lat-A, disassembling when exposed to 10 microM Lat-A for one hour. To determine how a change in the actin filaments during myofibrillogenesis might confer greater resistance to depolymerization by Lat-A, we stained the myotubes with an antibody directed against CapZ, a protein that blocks the release of monomer actin from the barbed ends of actin filaments. CapZ was absent from premyofibrils. It was distributed uniformly along nascent myofibrils where F-actin was unstriated, and was localized in a clearly striated Z-band pattern in the mature myofibrils where F-actin patterns were fully striated. These Lat-A and CapZ results are discussed in the context of various models of myofibrillogenesis.

Indexed as

ActininActinsAnimalsBridged Bicyclo Compounds, HeterocyclicCapZ Actin Capping ProteinCells, CulturedGreen Fluorescent ProteinsMicrofilament ProteinsMuscle ProteinsMuscle, SkeletalMyofibrilsQuailThiazolesThiazolidinesTransfectionActininActinsBridged Bicyclo Compounds, HeterocyclicCapZ Actin Capping ProteinGreen Fluorescent Proteinslatrunculin AMicrofilament ProteinsMuscle ProteinsThiazolesThiazolidines

Identifiers

PMID16080205
PMCPMC2771450
OpenAlexW2148804177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.